Correction: Memorial Hermann Orthopedic and Spine Hospital, Texas, USA, introduces Osseointegration Program with Integrum’s OPRA™ Implant System
The correction refers to the institutional affiliation of the physicians and Integrum clarifies the ownership to the claims of the benefits of the OPRA™ Implant System.
Integrum’s OPRA™ Implant System is now available at Memorial Hermann Orthopedic and Spine Hospital, Texas.
Memorial Hermann Orthopedic & Spine Hospital in Houston has launched an Osseointegration program with Integrum’s OPRA™ Implant System.
According to Integrum, Osseointegration (OI) is a life-changing surgical technique for amputees, in which an implant is anchored in the bone and directly attached to a prosthesis. OI eliminates the need for a prosthetic socket, the most challenging part of fitting a prosthesis, often leading to pain and skin/soft tissue problems. OI has been shown to improve function, walking ability and overall quality of life for people with limb loss.
Integrum’s OPRA™ Implant System consists of an anchorage element (Fixture) and a skin-penetrating device (Abutment). The Fixture is surgically inserted into the femur, and after a healing time of several months, the Abutment is connected to the Fixture. The prosthetic leg is then attached directly to the Abutment via the Axor™, a prosthetic connection and safety device.
“At the Center for Limb Optimization and Restoration, our interdisciplinary medical and rehabilitation team aims to provide exceptional patient care and expertise,” said Danielle Melton, M.D., a specialist in the rehabilitation of people with amputations and the Director of the Amputee Program at TIRR Memorial Hermann and associate professor in the Department of Orthopaedic Surgery at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). “We are focused on improving outcomes and getting our patients one step closer to achieving their potential. We are always looking for new ways to improve our patient’s quality of life.”
Besides Dr. Melton, the Osseointegration program is led by a team of UTHealth orthopedic surgeons including Matthew Koepplinger, DO, David Doherty. Jr, MD, Jim Kellam, MD and Ken Mathis, MD.
Integrum’s OPRA™ Implant System is the only FDA-approved, bone-anchored prosthetic solution available in the United States.
“We’re delighted to be collaborating with the team at Memorial Hermann,” said Maria Lopez, CEO of Integrum. “It’s an exciting time for osseoitegration in the United States and we are glad to see reputable health systems like Memorial Hermann adopt the technology.”
Memorial Hermann Orthopedic & Spine Hospital is part of the Memorial Hermann Health System, one of the largest not-for-profit health systems in Southeast Texas with 17* hospitals and numerous specialty programs and services conveniently located throughout the Greater Houston area.
The most comprehensive academic health center in the UT System and the U.S. Gulf Coast region, UTHealth is home to John P. and Kathrine G. McGovern Medical School, which includes the clinical practice UT Physicians, as well as five other schools. For more information, visit www.uth.edu.
UT Physicians will be hosting an Osseointegration Clinic on Friday, 18 Sep 2020. For a referral to UT Physicians, please call (713) 486-3550.
For further information, please contact:
Maria Lopez, CEO
Cell. 0708-46 10 69
Email: maria.lopez@integrum.se
Certified Adviser:
Erik Penser Bank AB
Tel. +46 8 463 8000
Email: certifiedadviser@penser.se
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North exchange) based outside of Gothenburg, Sweden with a U.S. subsidiary in San Francisco, CA. Since 1990 the OPRA™ Implant System has been helping individuals with amputations towards an improved quality of life. Thorough surgical experience gained over almost three decades from 500 surgeries in 14 countries has led to the development of Integrum’s system for bone-anchored prosthetics – a beneficial alternative to the traditionally used socket prosthesis. Integrum’s OPRA™ Implant System was approved by the U.S. Food and Drug Administration (FDA) in 2015 for use in the U.S. under a Humanitarian Use Device (HUD) designation which was reviewed through the Humanitarian Device Exemption (HDE) pathway. The OPRA™ Implant System is the only FDA approved technology for bone anchored prosthetics available in the U.S. More information on the company and its innovative solutions for amputees can be found at www.integrum.se.